Stock Quotes in this Article: CLSN, ENZN, NVGN, SMA, IBIO

MADISON, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

>>5 Stocks Under $10 Set to Soar

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside today.

>>5 Big Trades After the Fed Meeting

Novogen

Novogen (NVGN) researches, develops and markets pharmaceutical products. This stock closed up 1.2% to $4.13 on Thursday.

Thursday's Range: $4.01-$4.49

52-Week Range: $0.48-$10.49

Volume: 115,000

Three-Month Average Volume: 73,619

>>5 Stocks the Pros Love This Summer

From a technical perspective, NVGN ripped higher here right above some near-term support levels at $4 to $3.80 with above-average volume. This move is quickly pushing shares of NVGN within range of triggering a near-term breakout trade. That trade will hit if NVGN manages to take out both its 50-day at $4.40 and its 200-day at $4.50 and then once it clears more near-term resistance at $4.67 with high volume.

Traders should now look for long-biased trades in NVGN as long as it's trending above some key near-term support levels at $4 or $3.80 and then once it sustains a move or close above those breakout levels with volume that hits near or above 73,619 shares. If that breakout triggers soon, then NVGN will set up to re-test or possibly take out its next major overhead resistance levels at $5.50 to $5.80. Any high-volume move above those levels will then put its next major overhead resistance level at $6.92 into range for shares of NVGN.

Enzon Pharmaceuticals

Enzon Pharmaceuticals (ENZN) is engaged in the research and development of therapeutics for cancer patients primarily in the U.S. This stock closed up 0.59% to $1.71 on Thursday.

Thursday's Range: $1.68-$1.73

52-Week Range: $1.54-$7.47

Volume: 253,000

Three-Month Average Volume: 368,145

>>3 Health Care Stocks Spiking on Big Volume

From a technical perspective, ENZN bounced modestly higher here right above its 50-day moving average at $1.66 with lighter-than-average volume. This stock has been uptrending for the last two months, with shares moving higher from its low of $1.46 to its recent high of $1.83. During that move, shares of ENZN have been mostly making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of ENZN within range of triggering a near-term breakout trade. That trade will hit if ENZN manages to take out some near-term overhead resistance at $1.83 with high volume.

Traders should now look for long-biased trades in ENZN as long as it's trending above its 50-day at $1.66 or above some more support at $1.54 and then once it sustains a move or close above $1.83 with volume that hits near or above 368,145 shares. If that breakout triggers soon, then ENZN will set up to re-test or possibly take out its next major overhead resistance levels at $2 to $2.20. Any high-volume move above those levels will then put its next major overhead resistance level at $2.50 into range for shares of ENZN.

Celsion

Celsion (CLSN) is an innovative oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer. This stock closed up 9% to $1.33 on Thursday.

Thursday's Range: $1.26-$1.44

52-Week Range: $0.75-$9.44

Volume: 6.85 million

Three-Month Average Volume: 4.71 million

>>10 Tips for Trading Penny Stocks

From a technical perspective, CLSN ripped higher here right above its 50-day moving average at $1.15 with heavy upside volume. This move is quickly pushing shares of CLSN within range of triggering a major breakout trade. That trade will hit if CLSN manages to take out some near-term overhead resistance levels at $1.44 to $1.65 with high volume.

Traders should now look for long-biased trades in CLSN as long as it's trending above its 50-day at $1.15 or above some more key near-term support at $1.12 and then once it sustains a move or close above those breakout levels with volume that hits near or above 4.71 million shares. If that breakout triggers soon, then CLSN will set up to re-test or possibly take out its next major overhead resistance level at $2.10. Any high-volume move above $2.10 will then give CLSN a chance to re-fill its previous gap down zone from January that started above $8.

Symmetry Medical

Symmetry Medical (SMA) designs, develops and produces medical device solutions and surgical instruments. This stock closed up 0.39% to $7.76 on Thursday.

Thursday's Range: $7.53-$7.78

52-Week Range: $7.44-$12.83

Volume: 662,000

Three-Month Average Volume: 281,709

>>5 Cash-Rich Stocks to Triple Your Gains

From a technical perspective, SMA bounced modestly higher here right above its 52-week low of $7.44 with above-average volume. This stock has been downtrending badly for the last three months, with shares plunging from its high of $12.83 to its recent low of $7.44. During that downtrend, shares of SMA have been consistently making lower highs and lower lows, which is bearish technical price action. That move has now pushed shares of SMA into oversold territory, since its current relative strength index reading is just 19.14. Oversold can always get more oversold, but it's also an area where a stock can experience a powerful bounce higher from.

Traders should now look for long-biased trades in SMA as long as it's trending above its 52-week low at $7.44 and then once it sustains a move or close above some near-term overhead resistance at $8.10 with volume that hits near or above 281,709 shares. If we get that move soon, then SMA will set up to re-test or possibly take out its next major overhead resistance levels at $8.75 to around $9.50. Any high-volume move above those levels will then put its 200-day at $10.18 to its 50-day at $10.25 into range for shares of SMA.

iBio

iBio (IBIO) is a biotechnology company focused on developing vaccines and therapeutic proteins based upon its proprietary plant-based iBioLaunch Platform Technology. This stock closed up 6.6% to 48 cents per share on Thursday.

Thursday's Range: $0.44-$-0.49

52-Week Range: $0.33-$1.70

Volume: 454,000

Three-Month Average Volume: 176,006

>>5 Stocks Insiders Love Right Now

From a technical perspective, IBIO ripped higher here right off its 50-day moving average at 44 cents per share with above-average volume. This move is quickly pushing shares of IBIO within range of triggering a near-term breakout trade. That trade will hit if IBIO manages to take out some near-term overhead resistance at 54 cents with high volume.

Traders should now look for long-biased trades in IBIO as long as it's trending above its 50-day at 44 cents per share or above some more key near-term support at 39 cents per share and then once it sustains a move or close above 54 cents per share with volume that hits near or above 176,006 shares. If that breakout triggers soon, then IBIO will set up to re-test or possibly take out its next major overhead resistance levels at 69 cents to 70 cents per share. Any high-volume move above those levels will then put its next major overhead resistance levels at 74 cents to 82 cents per share within range for shares of IBIO.

To see more stocks that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Madison, Wis.

RELATED LINKS:

>>5 Hated Earnings Stocks That Deserve Your Love
>>3 Stocks With Ever-Increasing Dividends

>>5 Buy Signals From the Consumer Sector

Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Madison, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.